<ѻýҕl>HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapseѻýҕl> Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
<ѻýҕl>Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALLѻýҕl> However, it may benefit children at increased risk of thrombosis Nov 20, 2023
<ѻýҕl>Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohortѻýҕl> No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
<ѻýҕl>Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweensѻýҕl> Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
<ѻýҕl>Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceledѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 20, 2023
<ѻýҕl>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Careѻýҕl> News, features, and commentary about cancer-related issues Nov 17, 2023
<ѻýҕl>First AKT Inhibitor Approved for Advanced Breast Cancerѻýҕl> Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
<ѻýҕl>Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencersѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 17, 2023
<ѻýҕl>FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent'ѻýҕl> No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
<ѻýҕl>ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancerѻýҕl> Evidence from RCTs indicates "oncologic equivalence" between partial and whole-breast irradiation Nov 16, 2023
<ѻýҕl>FDA OKs New Option for Advanced ROS1-Positive Lung Cancerѻýҕl> Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
<ѻýҕl>'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinomaѻýҕl> Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
<ѻýҕl>FDA OKs Product to Thwart Bloodstream Infections During Dialysisѻýҕl> Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
<ѻýҕl>Targeting New Pathways to Improve Outcomes in Renal Cell Carcinomaѻýҕl> Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
<ѻýҕl>Lymphoma Drug Copanlisib to Be Pulled From U.S. Marketѻýҕl> Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
<ѻýҕl>Diabetes Linked to Higher Colorectal Cancer Riskѻýҕl> Associated risks highest in those with recent diagnoses Nov 14, 2023
<ѻýҕl>No Boost in Outcomes for Clear Cell RCC With Higher Belzutifan Doseѻýҕl> A quarter of patients responded whether at the recommended or higher dose Nov 13, 2023
<ѻýҕl>Pancreatic Cancer Doesn't Have to Be a Death Sentenceѻýҕl> Early detection is the key to increasing survival rates Nov 13, 2023
<ѻýҕl>Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinomaѻýҕl> Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients Nov 11, 2023
<ѻýҕl>Zoonotic Spillovers; DNA and RNA Testing for Cancer Riskѻýҕl> Also in TTHealthWatch: genes and health conditions among Icelanders Nov 11, 2023 podcast
<ѻýҕl>First Treatment Approved for Genetic Clotting Disorderѻýҕl> Adzynma indicated as prophylactic or on-demand enzyme replacement therapy in cTTP Nov 10, 2023
<ѻýҕl>Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Meshѻýҕl> News, features, and commentary about cancer-related issues Nov 10, 2023
<ѻýҕl>Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancerѻýҕl> Alone or combined with a PD-1 inhibitor, ubamatamab showed promise in phase I trial Nov 09, 2023
<ѻýҕl>Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparitiesѻýҕl> A "local heroes effect" can better reach communities of color Nov 09, 2023
<ѻýҕl>New Oral Drug Approved for Metastatic Colorectal Cancerѻýҕl> In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
<ѻýҕl>Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancersѻýҕl> Results look good, but more data needed Nov 08, 2023
<ѻýҕl>Senate Confirms Monica Bertagnolli as Next NIH Directorѻýҕl> Vote was 62-36 in favor of the current National Cancer Institute director Nov 07, 2023
<ѻýҕl>FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiatorsѻýҕl> With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
<ѻýҕl>T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancersѻýҕl> More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
<ѻýҕl>Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancerѻýҕl> Compared with simple hysterectomy, analysis shows more sexual toxicities, worse quality of life Nov 07, 2023
<ѻýҕl>Lung Cancer Survival High at 20 Years With Screen-Detected Tumorsѻýҕl> After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program Nov 07, 2023
<ѻýҕl>Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancerѻýҕl> Overall response beats historical benchmark, but misses significance target Nov 06, 2023
<ѻýҕl>RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancerѻýҕl> Impressive overall response rate with avutometinib-defactinib in RAMP 201 trial Nov 05, 2023
<ѻýҕl>Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancerѻýҕl> Particularly strong PFS signal seen in patients that were mismatch repair proficient Nov 05, 2023
<ѻýҕl>Adding Atezolizumab Improves Survival in Advanced Cervical Cancerѻýҕl> Trial confirms the role of first-line checkpoint inhibition in metastatic or recurrent disease Nov 03, 2023
<ѻýҕl>Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Sayѻýҕl> Devices are aimed at preventing metastasis during surgery Nov 03, 2023
<ѻýҕl>Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachiaѻýҕl> News, features, and commentary about cancer-related issues Nov 03, 2023
<ѻýҕl>Transitioning Cancer Survivors Away From Oncologic Careѻýҕl> It's time for a new model of care Nov 03, 2023
<ѻýҕl>False-Positive Mammograms May Indicate Higher Breast Cancer Risk in the Futureѻýҕl> Swedish cohort study shows a 61% increased risk over 20 years Nov 02, 2023
<ѻýҕl>Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosisѻýҕl> Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge Nov 02, 2023